Takamatsu, H <br/><br/>
Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 2017 
 - 2503-2510 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Bone Marrow Transplantation--methods<br/>Disease-Free Survival<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Melphalan--therapeutic use<br/>Multiple Myeloma--drug therapy<br/>Neoplasm, Residual--genetics<br/>Polymerase Chain Reaction--methods<br/>Prognosis<br/>Retrospective Studies<br/>Stem Cell Transplantation--methods<br/>Transplantation, Autologous<br/>Treatment Outcome